Symptoms: Akathisia, emotional blunting, cognitive impairment, insomnia, depersonalization/derealization, suicidal ideation, severe anxiety/panic, dyskinesia, GI disturbances
My daughter Mona Daniella died by suicide on September 26, 2016. Mona was a brilliant student, always in high honours, a published author by the age of 10, and volunteered to help the underprivileged. She was misdiagnosed with BPD at McLean Hospital and was prescribed various medications, including Lithium, Fluvoxamine, Prazosin, Neurontin, Seroquel, EMSAM patch, Klonopin, Vistaril, Prozac, and Zyprexa. Cogentin was used to treat akathisia.
When Mona first went to McLean, she was fully functional. After treatment, she was unable to even comb her hair or put a plate in the dishwasher. She then transferred to another treatment centre, which added Sertraline, Amphetamine, Gabapentin, Xanax, and others to her medication regimen.
In New York, Mona was correctly diagnosed with OCD and prescribed medications such as Zolpidem, Clomipramine, Klonopin, Vyvanse, Olanzapine, Prazosin, Benztropine Mesylate, Deplin, Fluvoxamine, Gabapentin, EMSAM, Suvorexant, Ziprasidone, and massive doses of Zyprexa—all via text, without an in-person assessment by a psychopharmacologist.
The day before her death, Mona showed symptoms like slurred speech and uncontrollable leg shaking. Each medication caused side effects, leading doctors to add more medications to her treatment.
After Mona’s death, we were told that what happened to her was “one perfect mistake after another perfect mistake after another perfect mistake.”